Your browser doesn't support javascript.
loading
A very rare presentation of mitochondrial elongation factor Tu deficiency-TUFM mutation and literature review.
Gokalp, Sabire; Inci, Asli; Kilic, Ayse; Ozsaydi, Ekin; Altun, Ayse Nur; Demir, Fevzi; Ergin, Filiz Basak; Ozbek, Mehmet Nuri; Okur, Ilyas; Ezgu, Fatih; Tumer, Leyla.
Afiliación
  • Gokalp S; Department of Pediatric Metabolic Disorders, Gazi University Faculty of Medicine, Ankara, Türkiye.
  • Inci A; Department of Pediatric Metabolic Disorders, Gazi University Faculty of Medicine, Ankara, Türkiye.
  • Kilic A; Department of Pediatric Metabolic Disorders, Gazi University Faculty of Medicine, Ankara, Türkiye.
  • Ozsaydi E; Department of Pediatric Metabolic Disorders, Gazi University Faculty of Medicine, Ankara, Türkiye.
  • Altun AN; Department of Pediatric Metabolic Disorders, Gazi University Faculty of Medicine, Ankara, Türkiye.
  • Demir F; Department of Pediatric Metabolic Disorders, Gazi University Faculty of Medicine, Ankara, Türkiye.
  • Ergin FB; Department of Pediatric Metabolic Disorders, Gazi University Faculty of Medicine, Ankara, Türkiye.
  • Ozbek MN; Department of Pediatrics, Dicle University Faculty of Medicine, Diyarbakir, Türkiye.
  • Okur I; Department of Pediatric Metabolic Disorders, Gazi University Faculty of Medicine, Ankara, Türkiye.
  • Ezgu F; Department of Pediatric Metabolic Disorders, Gazi University Faculty of Medicine, Ankara, Türkiye.
  • Tumer L; Department of Pediatric Metabolic Disorders, Gazi University Faculty of Medicine, Ankara, Türkiye.
J Pediatr Endocrinol Metab ; 37(6): 571-574, 2024 Jun 25.
Article en En | MEDLINE | ID: mdl-38630895
ABSTRACT

OBJECTIVES:

The mitochondrial elongation factor Tu (EF-Tu), encoded by the TUFM gene, is a GTPase, which is part of the mitochondrial protein translation mechanism. If it is activated, it delivers the aminoacyl-tRNAs to the mitochondrial ribosome. Here, a patient was described with a homozygous missense variant in the TUFM [c.1016G>A (p.Arg339Gln)] gene. To date, only six patients have been reported with bi-allelic pathogenic variants in TUFM, leading to combined oxidative phosphorylation deficiency 4 (COXPD4) characterized by severe early-onset lactic acidosis, encephalopathy, and cardiomyopathy. CASE PRESENTATION The patient presented here had the phenotypic features of TUFM-related disease, lactic acidosis, hypotonia, liver dysfunction, optic atrophy, and mild encephalopathy.

CONCLUSIONS:

We aimed to expand the clinical spectrum of pathogenic variants of TUFM.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor Tu de Elongación Peptídica Límite: Humans Idioma: En Revista: J Pediatr Endocrinol Metab Asunto de la revista: ENDOCRINOLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor Tu de Elongación Peptídica Límite: Humans Idioma: En Revista: J Pediatr Endocrinol Metab Asunto de la revista: ENDOCRINOLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article